2023 WCLC Highlights Webinar
Webinar | English | 60 Min
Image For Activity Cover
Credit Offered
1 ACCME Credit
1 Certificate of Attendance Credit

Dr. Navneet Singh, MD DM (India) will moderate the program and lead the discussion and Q&A following panel presentations by Christian Rolfo, MD, PhD, MBA (USA), Clarissa Baldotto, MD, PhD (Brazil), and Lizza Hendricks, MD, PhD (Netherlands). Topics of discussion include EGFRm advanced NSCLC (FLAURA2), stereotactic ablative radiotherapy (I-SABR study), surgical outcomes in resectable NSCLC (AEGEAN), cardiovascular effects of immunotherapy, PD-L1 tumour cell scoring, and the 9th edition of TNM Classification for lung cancer. Brought to you by IASLC's Education Committee.

Live Activity Date: October 23, 2023
Enduring Activity Launch Date: December 19, 2023
Enduring Activity Expiration Date: December 18, 2024
Physicians and researchers.
Upon completion of this activity, the participants should be able to:
  • Evaluate the role of EGFR targeted therapy in combination with chemotherapy as first-line treatment for metastatic NSCLC harboring common EGFR mutations.
  • Identify updates in the TNM staging of lung cancer.
  • Describe the role of immunotherapy for early-stage NSCLC.
  • Recognize the potential cardiovascular adverse effects of immunotherapy. 
  • Navneet Singh, MD, DM FRCP (London) FASCO, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India 
  • Clarissa Baldotto, MD, PhD, The Brazilian Group of Thoracic Oncology, Brazil
  • Lizza Hendricks, MD, PhD, Maastricht University Medical Center, The Netherlands
  • Christian Rolfo, MD, PhD, MBA, The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, New York, NY, USA
The following planners, speakers, reviewers, or staff have relevant financial relationships to disclose: 

Full Legal Name Commercial Interest Role Level of Participation in the Activity
Christian Rolfo AstraZeneca Speaker Planner/Speaker
  Roche Speaker  
  MSD Speaker  
  Inivata Speaker  
  Archer Speaker  
  Boston Pharmaceuticals Speaker  
  MD Serono/Novartis Speaker  
  Bayer Speaker  
  Invitae Speaker  
  Egeneron Speaker  
  Bostongene Speaker  
  Imagene Advisor Planner/Speaker
Clarissa Baldotto AstraZeneca Advisor/Speaker Speaker
  Roche Advisor  
  Roche Brazil Speaker  
  Pfizer Advisor  
  Takeda Speaker  
  MSD Brazil Advisor/Speaker  
  Novartis Advisor  
  Janssen Advisor/Speaker  
Lizza Hendriks Amgen Advisor  
  Boehringer Ingelheim Advisor/Research Funding  
  Lilly Advisor/Speaker Speaker
  Novartis Advisor/Research Funding  
  Pfizer Advisor/Research Funding/Speaker  
  Takeda Advisor/Research Funding/Speaker  
  Merck Advisor/Research Funding  
  MSD Advisor/Speaker  
  Anheart Advisor  
  AstraZeneca Research Funding/Speaker  
  Bayer Speaker  
  High5oncology Speaker  
  GSK Speaker  
  Sanofi speaker Speaker
  Roche Reserach Funding  

"I have at present or have had within the last 24 months, a financial relationship with one or more ineligible companies."

These relationships with ineligible companies have been mitigated by the International Association for the Stufy of Lung Cancer (IASLC). 

All other presenters, planners, editors, or staff report no relationshops to disclose:

"I do not have at present nor have had within the last 24 months, any financial relationships with ineligible companies."

Accreditation Statement: 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements:

The International Association for the Study of Lung Cancer designates the enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Registered Nurses
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education).

Physician Assistants
The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.

International CPD Credit Reciprocity Agreements

The Royal College will recognize the number of participation hours as MOC Program Section 1 accredited group learning credits for group learning activities developed by Accreditation Council for Continuing Medical Education (ACCME)-accredited physician organizations (university, academy, specialty society, hospital department etc.) that are held within and outside of Canada. Agreement dates: November 1, 2019 to December 31, 2025.

European Union
The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

The American Medical Association (AMA) and the Department of Healthcare Professions–Accreditation Section (DHP-AS), Ministry of Public Health–Qatar have renewed their CME agreement under which select activities approved for AMA PRA Category 1 Credit™ are eligible for conversion of the hours of participation to Department of Healthcare Professions Continuing Professional Development (DHP-CPD) credit. This agreement is in place through Dec. 31, 2026.
The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; participants should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:
  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out, if applicable.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test.
  4. Complete the activity evaluation to provide feedback for future programming and receive credit.
You may now view or print the certificate from your CME/CE Transcript. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Transcript and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Transcript.

*The credit that you receive is based on your membership profile.
If you need assistance with this activity, please email: education@iaslc.org.
Powered By